Home Investors Stock & Rating Information Stock & Rating Information Important Notice This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider. I Agree Fiscal Year End March 31 Annual Shareholders' Meeting June Record Date for Dividend Year-end dividend - March 31 Interim dividend - September 30 Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment. Stock Trading Unit 100 shares Stock Exchange Listings Tokyo Stock Exchange, Osaka Stock Exchange Ticker Code 4503 Articles of Incorporation Articles of Incorporation（pdf 72KB） Share Handling Regulations Share Handling Regulations（pdf 286KB） Special Benefits Program for Shareholders None INVESTORS Corporate Strategic Plan 2021 Financial Information Annual Report IR Library IR Calendar Stock & Rating Information Shareholders Meeting Shareholder Return Current Share Status Chart Issuer Rating Analyst Coverage Cautionary Statement Bottom footer menu SITE MAP PRIVACY POLICY ACCESSIBILITY TERMS OF USE CONTACT US DISASTER INFORMATION FOR EMPLOYEES © Astellas Pharma Inc.